Sign in
bf/NASDAQ:AKLI_icon.png

NASDAQ:AKLI

Akili, Inc.

  • Stock

USD

Last Close

0.43

01/07 20:00

Market Cap

34.10M

Beta: -

Volume Today

236.45K

Avg: 55.16K

PE Ratio

−0.28

PFCF: −0.27

OverviewFinancialsFilingspeopleOwnershipAPIChartData

  • locale

    usUnited States

  • market

    STOCKS

  • industry

    Medical - Healthcare Information Services

  • website

    www.akiliinteractive.com

  • ipo date

    Jun 30, 2021

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

peer of

Earnings

Earnings Release in 12 days

Earnings per Share (Estimate*)

-0.6-0.5-0.4-0.3-0.2-0.12020-12-312022-03-232022-08-122023-03-072023-08-102024-03-05

Revenue (Estimate*)

200K400K600K800K2020-12-312022-03-232022-08-122023-03-072023-08-102024-03-05

*Estimate based on analyst consensus